Thirdly, in many Hh pathway overexpressing cancers, GLI proteins (especially GLI1) are the most consistently upregulated component among the Hh pathway elements and are intimately associated with poor prognosis in cancer patients, making them more practical therapeutic targets in a wide variety of tumors. Here, GLI1 is linked to cancer.